{"company":{"id":2309456,"name":"Nuclidium","domain":"nuclidium.com","url":"https://alion.io/company/nuclidium"},"section":"news","answer":"Nuclidium: 15 headlines on record, 0 headlines in the last 90 days. Its story counts 5 milestones.","figures":[{"label":"Headlines","value":"15"},{"label":"In 90 days","value":"0"},{"label":"Milestones","value":"5"}],"blocks":[{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":5}],"story":[{"title":"Raised a round Series B","url":"https://nuclidium.com/nuclidium-announces-closing-of-series-b-extension-bringing-total-round-to-chf-105-million/"},{"title":"Raised a round Series B $88.5M","url":"https://streetinsider.com/Globe+Newswire/NUCLIDIUM+Closes+CHF+79+Million+%28EUR+84+Million%29+Series+B+Financing+to+Advance+Clinical+Development+of+its+Copper-based+Radiopharmaceutical+Platform/25035214.html"},{"title":"Board appointment NUCLIDIUM Appoints Tony Rosenberg as Chairman of the Board · businesswire.com","url":"https://businesswire.com/news/home/20241120381092/en/NUCLIDIUM-Appoints-Tony-Rosenberg-as-Chairman-of-the-Board/"},{"title":"Partnership NUCLIDIUM and PharmaLogic Form Strategic Partnership for Sustainable Development of Novel Copper-based Theranostics to Diagnose and Treat Solid Tumou… · businesswire.com","url":"https://businesswire.com/news/home/20230515005088/en/NUCLIDIUM-and-PharmaLogic-Form-Strategic-Partnership-for-Sustainable-Development-of-Novel-Copper-based-Theranostics-to-Diagnose-and-Treat-Solid-Tumours"},{"title":"Website went live first capture in the Wayback Machine","url":"https://web.archive.org/web/20211219234849/nuclidium.com"}],"as_of":"2026-11-22","cite":"Nuclidium, News. Alion, Nov 22, 2026. https://alion.io/company/nuclidium/news","html_url":"https://alion.io/company/nuclidium/news","json_url":"https://alion.io/company/nuclidium/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-22T19:42:29Z"}}